Bragar Eagel & Squire, PC investigates Natera, Nuvei, Corcept Therapeutics, and… | Nation/World

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Natera, Inc. (NASDAQ : NTRA), Nuvei Corporation (NASDAQ: NVEI ), Corcept Therapeutics, Inc. (NASDAQ: CORT) and Agrify Corporation (NASDAQ: AGFY). Our investigations focus on whether these companies have violated federal securities laws and/or engaged in other illegal business practices. Additional information on each case can be found at the link provided.

Natera, Inc. (NASDAQ: NTRA)

On January 1, 2022, a New York Times article questioned the accuracy of some prenatal tests, alleging that positive test results are incorrect about 85% of the time, and that patients who receive a positive result are expected to continue follow-up tests, which “can cost thousands of dollars, carry a low risk of miscarriage, and can only be done later in pregnancy.”

On this news, Natera’s stock fell 3.5% in intraday trading on January 3, 2022, hurting investors.

For more information on the Natera survey, visit: https://bespc.com/cases/NTRA

Nuvei Corporation (NASDAQ: NVEI)

On December 8, 2021, Spruce Point Capital Management (“Spruce Point”) released a short sale report on Nuvei. Citing “a forensic financial and accounting review,” the Spruce Point report alleged that Nuvei “covered up a pattern of business failures, a lack of organic growth, and a network of relationships with individuals linked to major Ponzi schemes. and suspected fraudulent activities.[.]”

Following the release of Spruce Point’s report, Nuvei’s share price fell $39.38 or 40.45%, to close at $57.97 per share on December 8, 2021.

For more information on the Nuvei survey, visit: https://bespc.com/cases/NVEI

Corcept Therapeutics, Inc. (NASDAQ: CORT)

On December 8, 2021, Corcept disclosed in a filing with the United States Securities and Exchange Commission that “[o]On November 15, 2021, the Company received a subpoena from the United States Attorney’s Office for the District of New Jersey (the “NJ USAO”) pursuant to Section 248 of the Portability and Accountability Act of 1996. (HIPAA) requesting information regarding the sale and promotion of Korlym, Corcept’s relationships and payments with healthcare professionals who may prescribe or recommend Korlym, and prior authorization and reimbursement of Korlym. Corcept further revealed that “[t]The NJ USAO has notified Corcept that it is investigating whether any criminal or civil violations by Corcept have occurred in connection with the matters referenced in the subpoena.

On this news, Corcept’s stock price fell $3.71 per share, or 16.91%, to close at $18.23 per share on December 8, 2021.

For more information on the Corcept survey, visit: https://bespc.com/cases/CORT

Agrify Corporation (NASDAQ:AGFY)

On December 16, 2021, during trading hours, market analyst Bonitas Research released a report regarding Agrify which alleges several issues within the company, including that “[w]We believe Agrify has created artificial demand for its product by funding undisclosed insiders of the company to act as independent customers. Further, the report alleges that “Agrify insiders lied to investors about the independence of its client base in order to execute a questionable stock promotion for personal enrichment at the expense of minority shareholders.”[,]” and that “[e]Evidence showed that five (5) of Agrify’s eight (8) customer announcements in 2021 involved either undisclosed company insiders or unlicensed and unproven operators.

At this news, Agrify’s common stock price fell sharply during intraday trading on December 16, 2021.

For more information on the Agrify survey, visit: https://bespc.com/cases/AGFY

About Bragar Eagel & Squire, PC:

Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation before state and federal courts across the country. For more information about the company, please visit www.bespc.com. Lawyer advertisement. Prior results do not guarantee similar results.

Contact details:

Bragar Eagel & Squire, CP

Brandon Walker, Esq.

Alexandra B. Raymond, Esq.

(212) 355-4648

[email protected]

www.bespc.com

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.